YIH
OPTN

Y-Intercept (HK)’s OptiNose OPTN Stock Holding History

Y-Intercept (HK)’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,654
Closed -$88.2K – 1665
2024
Q2 		$88.2K Buy
+5,654
New +$94.7K ﹤0.01% 1272
2023
Q2 		– Sell
-1,269
Closed -$36.7K – 1593
2023
Q1 		$36.7K Buy
+1,269
New +$33.8K ﹤0.01% 1114

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Y-Intercept (HK)'s OPTN Position: Q3 2024 in Review

Y-Intercept (HK) sold out of OptiNose (OPTN) in Q3 2024, closing a stake of 5,654 shares — an estimated $88.2K sold.

Y-Intercept (HK) first reported a position in OPTN in Q1 2023 and held it in 2 quarters. The position peaked at $88.2K in Q2 2024. 65 funds tracked by Wall St. Rank hold OPTN as of Q3 2024.

  • Y-Intercept (HK) reported no remaining OptiNose position as of Q3 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 5,654 OptiNose shares in Q3 2024, an estimated $88.2K.
  • Y-Intercept (HK) first reported a position in OptiNose in Q1 2023 and held it in 2 quarters.
  • Y-Intercept (HK)'s OptiNose position peaked at $88.2K in Q2 2024.
  • 65 funds tracked by Wall St. Rank held OptiNose as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.